PCSA•benzinga•
Processa Pharmaceuticals Files Base Prospectus For Up To $50M In Securities; Covers Up To $2.4M Of Common Stock To Be Issued And Sold Under Sales Agreement With A.G.P./Alliance Global Partners
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2024 by benzinga